Berkeley Lights, Inc. Common Stock

Compare this stock

BLI Stock Report Card

Today's performance

31%

Performance

Score:

10/100

BLI returned -83.56% in the last 12 months. Based on the other stocks in it's sector with an average return of -31.49%, it's performance is below average giving it a grade of 10 of 100.

Forecast

Score:

75/100

5 analysts offer 12-month price forecasts for BLI. Together, they have an average target of 0, the most optimistic forecast put BLI at 0 within 12-months and the most pessimistic has BLI at 0.

Sentiment

Score:

62/100

BLI had a bullish sentiment score of 62.13% across Twitter and StockTwits over the last 12 months. It had an average of 5.53 posts, 0.77 comments, and 1.49 likes per day.

Technicals

Score:

11/100

BLI receieves a 10 of 100 based on 14 indicators. 1 are bullish, 12 are bearish.

Earnings

Score:

10/100

BLI has missed earnings 7 times in the last 20 quarters.

Profit

Score:

10/100

Out of the last 10 quarters, BLI has had 0 profitable quarters and has increased their profits year over year on 0 of them.

Volatility

Score:

42/100

BLI has had a lower than average amount of volatility over the last 12 months giving it a grade of 42 of 100.

Berkeley Lights, Inc. Common Stock Summary

Nasdaq / BLI

Healthcare

Biotechnology

Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.

Power up your portfolio